Medpace Holdings, Inc.
MEDP- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001668397
In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 699 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.
Holders of 5% or more of MEDP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Medpace Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Troendle August J. | 13D/A | 20.00%5.68M shares | +0.50 ppfrom 19.50% | Mar 11, 20252 filings | Dec 1, 2025 | SEC |
| Price T Rowe Associates Inc | 13G | 7.20%2.07M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Medpace Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:38 AM ET | Price T Rowe Associates Inc | 13G | 7.20%2.07M shares | New | Jun 30, 2026 | SEC |
| Mar 27, 202610:33 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Dec 1, 20258:35 PM ET | Troendle August J.and 1 other | 13D/A | 20.00%5.68M shares | +0.50 ppfrom 19.50% | Nov 26, 2025 | SEC |
| Mar 11, 20259:30 PM ET | Troendle August J.and 1 other | 13D/A | 19.50%6.02M shares | – | Mar 7, 2025 | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Sep 21, 2022 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Sep 13, 2022 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Jul 6, 2022 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 27, 20225:13 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20229:16 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Dec 23, 2021 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Sep 1, 2021 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Apr 21, 2021 | Troendle August J. | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Wasatch Advisors Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20216:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Medpace Holdings, Inc. shares.
No Form 144 notices for Medpace Holdings, Inc. are on file.